PRESS RELEASE
News
-
-
PRESS RELEASE
EQS-Adhoc: E.ON SE: Preliminary financial results for the financial year 2023
E.ON SE expects preliminary financial results for the financial year 2023 with Adjusted Group EBITDA, EBITDA for the Energy Networks segment, EBITDA for the Customer Solutions segment, Net Income, and Earnings Per Share surpassing forecasts. The full financial results will be published on 13 March 2024 -
-
REGULATED PRESS RELEASE
NRJ GROUP - Press release - 2023 revenue
NRJ Group reports continued strong growth in consolidated revenue for the 4th quarter of 2023, with radio and broadcasting activities leading the way, despite a slight drop in television revenue. The impressive audience share and commercial performance of NRJ's radio stations also contributed to this solid performance -
REGULATED PRESS RELEASE
NRJ GROUP - Avis financier - Chiffre d'affaires 2023
NRJ Group enregistre une croissance soutenue du chiffre d'affaires consolidé au 4e trimestre 2023, avec une hausse de +5,1%, notamment grâce aux performances exceptionnelles de ses radios et à une progression de l'offre commerciale radio -
-
PRESS RELEASE
TUI AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
TUI AG releases notification of major holdings by The Goldman Sachs Group, Inc. with a change in breakdown of voting rights on subsidiary level -
-
REGULATED PRESS RELEASE
Crit confirme son intention d’acquérir OpenjobMetis à l’issue des « Due Diligences »
Groupe Crit confirme son intention d’acquérir OpenjobMetis à l’issue des « Due Diligences ». L'acquisition serait subordonnée à la finalisation des accords de cession et à la levée de la condition suspensive relative aux autorisations administratives (anti-trust & Golden Power). Prochain rendez-vous : Résultats annuels 2023 : 19 mars 2024 après Bourse -
PRESS RELEASE
Global Community of Hematopoietic Cell Transplantation and Cellular Therapy Specialists to Gather for the 2024 Tandem Meetings
The 2024 Tandem Meetings will unite international hematopoietic cell transplantation and cellular therapy specialists to discuss advancements and share insights in healthcare. The event will feature plenary and concurrent sessions, late-breaking abstracts, a poster hall, and an exhibit hall
